Neoantigen Identification

Neoantigen Identification is the computational and immunogenomic process of detecting tumor-specific peptides derived from somatic mutations that are predicted to bind to major histocompatibility complex molecules and elicit an adaptive immune response, thereby distinguishing them from normal self-antigens in the context of cancer immunotherapy research.

234

Publications

18.4K

Citations

2.2K

Authors

578

Institutions

Publications per year

2017–2026

187

Authors

2.2K

  1. SA
    Steven A. Rosenberg

    National Cancer Institute, United States

    10 publications · 1.2K citations

    10

    h-index

  2. PF
    Paul F. Robbins

    National Cancer Institute, United States

    8 publications · 1K citations

    8

    h-index

  3. ER
    Elaine R. Mardis

    Washington University in St. Louis, United States

    8 publications · 1.3K citations

    8

    h-index

  4. MB
    Michal Bassani‐Sternberg

    Ludwig Cancer Research, Switzerland

    8 publications · 1.8K citations

    8

    h-index

  5. JJ
    Jared J. Gartner

    National Cancer Institute, United States

    7 publications · 977 citations

    7

    h-index

1–5 of 2.2K

Venues

  1. Frontiers in Immunology

    16 publications · 888 citations

    14

    h-index

  2. Journal for ImmunoTherapy of Cancer

    JITC · 15 publications · 698 citations

    14

    h-index

  3. OncoImmunology

    13 publications · 576 citations

    13

    h-index

  4. Cancer Immunology Research

    11 publications · 1.4K citations

    11

    h-index

  5. Bioinformatics

    9 publications · 474 citations

    9

    h-index

1–5